These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7977509)

  • 1. Cladribine (Leustatin). Single-dose treatment for leukemia.
    Am J Nurs; 1994 Nov; 94(11):59-60. PubMed ID: 7977509
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose cladribine for symptomatic hairy cell leukaemia.
    Juliusson G; Lenkei R; Tjønnfjord G; Heldal D; Liliemark J
    Br J Haematol; 1995 Mar; 89(3):637-9. PubMed ID: 7734367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine.
    Tousi B; D'Silva R; Papish S
    Clin Lab Haematol; 2002 Aug; 24(4):259-60. PubMed ID: 12181031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Criteria for use of cladribine in adults.
    Fedak MN
    Am J Hosp Pharm; 1994 Sep; 51(17):2185-6. PubMed ID: 7985700
    [No Abstract]   [Full Text] [Related]  

  • 5. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder stones formation eight months after treatment of hairy-cell leukemia with 2-chloro-deoxyadenosine: a case report.
    Bessa O
    Conn Med; 1995 Jun; 59(6):331. PubMed ID: 7648851
    [No Abstract]   [Full Text] [Related]  

  • 7. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia.
    Goldschmidt N; Ganzel C; Attias D; Gatt M; Polliack A; Tadmor T
    Acta Haematol; 2014; 132(1):118-21. PubMed ID: 24557414
    [No Abstract]   [Full Text] [Related]  

  • 8. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cladribine underdosing in hairy-cell leukemia: a cause for apparent response failure.
    Golde DW; Jakubowiak A; Caggiano J; Heaney ML
    Leuk Lymphoma; 2002 Feb; 43(2):365-7. PubMed ID: 11999571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug bulletin. Cladribine injection (leustatin).
    RN; 1994 Mar; 57(3):41-2. PubMed ID: 8128145
    [No Abstract]   [Full Text] [Related]  

  • 11. Histological examination of the lacrimal gland after experimental administration of Cladribine.
    Kwietniewska M; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):526-30. PubMed ID: 12898890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
    Tobinai K; Ogura M; Hotta T; Kobayashi Y; Narabayashi M; Suzuki R; Kinoshita T; Kozuru M; Uike N; Ohashi Y
    Jpn J Clin Oncol; 1997 Jun; 27(3):146-53. PubMed ID: 9255268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of one hairy cell leukemia case with single course of cladribine].
    Zhang LJ; Qiu HX; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):336. PubMed ID: 21729604
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine.
    Seshadri P
    Leuk Res; 2000 Jul; 24(7):637. PubMed ID: 10979762
    [No Abstract]   [Full Text] [Related]  

  • 15. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Blood; 1997 Mar; 89(5):1838-9. PubMed ID: 9057674
    [No Abstract]   [Full Text] [Related]  

  • 16. Purpuric rash following treatment with 2-chlorodeoxyadenosine.
    Hendrick A
    Clin Lab Haematol; 2001 Feb; 23(1):67-8. PubMed ID: 11422236
    [No Abstract]   [Full Text] [Related]  

  • 17. High incidence of skin rash in patients with hairy cell leukemia treated with cladribine.
    Ganzel C; Gatt ME; Maly A; Ben-Yehuda D; Goldschmidt N
    Leuk Lymphoma; 2012 Jun; 53(6):1169-73. PubMed ID: 22035415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission.
    Girardi K; Paviglianiti A; Cirillo M; Bianchi A; Gherardi G; Annibali O; Cerchiara E; Marchesi F; Tomarchio V; Miglio C; Tirindelli M; Onetti Muda A; Avvisati G
    J Clin Exp Hematop; 2012; 52(1):31-4. PubMed ID: 22706528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.
    Zenhäusern R; Von Rohr A; Rufibach K; Solenthaler M; Meyer-Monard S; Gratwohl A; Hess U; Bargetzi MJ; Kovacsovic T; Leoncini L; Tobler A;
    Leuk Lymphoma; 2009 Jan; 50(1):133-6. PubMed ID: 19152171
    [No Abstract]   [Full Text] [Related]  

  • 20. Gynecomastia in a case of hairy cell leukaemia--cladribine induced?
    Abhyankar D; Saikia T; Advani S
    Leuk Lymphoma; 2001 Jun; 42(1-2):243-6. PubMed ID: 11699216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.